Steve Bernstein
Analyst · Janney Montgomery. Your line is live
Thank you, Tom and good afternoon. Before I give you the financial report for the second quarter of fiscal ‘23, I just wanted to give you a brief explanation relating to the delay in filing the 10-Q as well as the restated fiscal ‘22 10-K. During the preparation of the current 10-Q for the period ending October 31, ‘22, we realized there was a formula error in the calculation that split contract assets and contract liabilities from a net presentation to a gross presentation. The net number is correct. However, our formula didn’t split the assets and liabilities of related contracts being calculated as one project for revenue purposes. For example, if there were three related contracts that made up one complete project, two with a contract asset of $1.5 million each and one with a contract liability of $1 million, our formula would have recorded a contract asset of $2 million instead of a contract asset of $3 million and a contract liability of $1 million. As we put together footnote C in the 10-Q to show the effect of the formula change going back in time, it was determined that it was an immaterial error and that it would be only footnoted to show the effect going back. It was also determined that when the fiscal year Form 10-K for the period ended April 30, ‘22 was filed with our stated fiscal year ‘21 contract assets and contract liabilities shown gross as opposed to net as was shown in the fiscal year ‘21 annual report on Form 10-K, the footnote was deficient in that it did not disclose to the reader that the fiscal year ‘21 contract assets and contract liabilities will change from net to gross. As a result, we had to amend the fiscal year ‘22 annual report on Form 10-K to advise the public not to rely upon the financial statements as well as the controls on financial reporting. It is a GAAP requirement to disclose the change that were made with regards to the fiscal year ‘21 presentation changes in the annual report on Form 10-K for the period ending April 30, ‘22. But management wanted to clarify the situation, despite the emission to disclose the reader of the financial statements that the contract assets and contract liabilities were changed from net to gross presentation, management feels that the financial statements were accurate and could be relied upon, other than the formula mentioned above, all of the information, a reader of the financial statements needed was in the financials and was completely accurate. The only thing causing this restatement and delay in filing was the correction of a footnote to make the reader aware that the contract assets and contract liabilities, which changed on the face of the FY ‘21 balance sheet from net to gross. However, it was shown gross in the supporting footnotes. I should also mention that this change does not affect the P&L, working capital or any other calculation that would have helped in evaluating the financial statements as presented is because of these reasons that management of the company feels that the financials were accurate and could be relied upon. I believe I have said enough about this subject. However, if you want more details, feel free to contact me after the call. And now, I will go into the financials for the second quarter of fiscal ‘23. For the 6 months ending October 31, ‘22, consolidated revenue was $17.2 million compared to $25.9 million for the same period of the prior fiscal year. The components of revenue were as follows. Revenue from commercial and U.S. government satellite programs was approximately $7.8 million or 46% compared to $13.3 million or 52% in the same period of the prior fiscal year. Revenues on satellite payload contracts are recognized primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments were $8 million compared to $10.6 million in the same period of the prior fiscal year and accounted for approximately 47% of consolidated revenue compared to 41% for the prior fiscal year. Other commercial and industrial revenues were $1.4 million compared to $2 million in the prior fiscal year. Consolidated revenues increased quarter-over-quarter by approximately $750,000 or 9.1%. Intersegment revenues are eliminated in consolidation. For the 6 months ending October 31, ‘22, gross margin and gross margin rate decreased as compared to the same period in fiscal year ‘22. The decrease in gross margin and gross margin rate was due to increased engineering costs on development phase programs and experienced particularly complex technical challenges that have since been resolved. Minor technical challenges that have been or will be resolved reasonably quickly and the negative cost impacts of some programs due to supply chain delays. Gross margin was also affected by under-absorption of costs due to decrease in sales during the 6-month period ending October 31, ‘22. For the 6 months ending October 31, ‘22 and ‘21, SG&A expenses were approximately 23% and 26% respectively of consolidated revenue. The decrease in SG&A expense for the 6 month ending October 31, ‘22 as compared to the prior year was largely due to decrease in professional fees as well as one-time reductions to stock option expense related to forfeitures and deferred compensation expense. The company continues to monitor expenses looking for additional cost -effective reductions going forward. R&D expense for the 6 months ending October 31, ‘22 decreased to $1.7 million from $2.7 million for the 6 months ending October 31, ‘21, a decrease of $1 million and was approximately 10% and 11% respectively of consolidated revenue. The R&D decreases for the first half of the fiscal year ‘23 are related to focus on projects currently in production phase. The company plans to continue to invest in R&D in the future to keep its products at the state-of-the-art. For the 6 months ending October 31, ‘22, the company recorded an operating loss of $5.4 million compared to an operating loss of $1.4 million in the prior year. Operating losses resulted largely from decrease in revenue, coupled with the additional costs mentioned previously regarding gross margin. Operating loss improved quarter-over-quarter by approximately $120,000 or 26.5%. Other income consisted primarily investment income derived from the company’s holdings of marketable securities, Earnings on these securities made based on fluctuating interest rates, dividend payout levels and the timing of purchase sales redemptions or maturities of securities. This yields a pre-tax loss of approximately $5.4 million compared to $1.1 million pre-tax loss for the prior fiscal year. For the 6 months ending October 31, ‘22, the company recorded a tax provision of $2,200 compared to $2,300 for the same period of the prior fiscal year. Consolidated net loss for the 6 months ending October 31, ‘22 was $5.4 million or $0.58 per share compared to $1.1 million net loss or $0.12 per share in the prior fiscal year. Our fully funded backlog at the end of October ‘22 was approximately $56 million compared to approximately $40 million for the previous fiscal year end April 30, ‘22. The company’s balance sheet continues to reflect a strong working capital position of approximately $28 million at October 31, ‘22 and a current ratio of approximately 3.9:1. Additionally, the company is debt free. The company believes that its liquidity is adequate to meet the operating investing needs for the next 12 months and the foreseeable future. I will turn the call back to Tom and we look forward to your questions soon.